Mangalam Drugs & Organics Ltd

BOM:532637 (India)  
₹ 97.70 (-2.79%) Jun 4
At Loss
P/B:
1.14
Market Cap:
₹ 1.58B ($ 18.96M)
Enterprise V:
₹ 2.51B ($ 30.09M)
Volume:
6.90K
Avg Vol (2M):
7.98K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Mangalam Drugs & Organics Ltd ( ) from 2005 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Mangalam Drugs & Organics stock (BOM:532637) PE ratio as of Jun 05 2024 is 0. More Details

Mangalam Drugs & Organics Ltd (BOM:532637) PE Ratio (TTM) Chart

To

Mangalam Drugs & Organics Ltd (BOM:532637) PE Ratio (TTM) Historical Data

Total 1236
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Mangalam Drugs & Organics PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-06 At Loss 2024-03-26 At Loss
2024-06-04 At Loss 2024-03-22 At Loss
2024-06-03 At Loss 2024-03-21 At Loss
2024-05-31 At Loss 2024-03-20 At Loss
2024-05-29 At Loss 2024-03-19 At Loss
2024-05-28 At Loss 2024-03-18 At Loss
2024-05-27 At Loss 2024-03-14 At Loss
2024-05-24 At Loss 2024-03-13 At Loss
2024-05-23 At Loss 2024-03-12 At Loss
2024-05-22 At Loss 2024-03-11 At Loss
2024-05-21 At Loss 2024-03-07 At Loss
2024-05-17 At Loss 2024-03-06 At Loss
2024-05-16 At Loss 2024-03-05 At Loss
2024-05-15 At Loss 2024-03-04 At Loss
2024-05-14 At Loss 2024-03-01 At Loss
2024-05-13 At Loss 2024-02-29 At Loss
2024-05-10 At Loss 2024-02-28 At Loss
2024-05-09 At Loss 2024-02-27 At Loss
2024-05-08 At Loss 2024-02-26 At Loss
2024-05-07 At Loss 2024-02-23 At Loss
2024-05-06 At Loss 2024-02-22 At Loss
2024-05-03 At Loss 2024-02-21 At Loss
2024-05-02 At Loss 2024-02-20 At Loss
2024-04-30 At Loss 2024-02-19 At Loss
2024-04-29 At Loss 2024-02-16 At Loss
2024-04-26 At Loss 2024-02-15 At Loss
2024-04-25 At Loss 2024-02-14 At Loss
2024-04-24 At Loss 2024-02-13 At Loss
2024-04-23 At Loss 2024-02-12 At Loss
2024-04-22 At Loss 2024-02-09 At Loss
2024-04-19 At Loss 2024-02-08 At Loss
2024-04-18 At Loss 2024-02-07 At Loss
2024-04-16 At Loss 2024-02-06 At Loss
2024-04-15 At Loss 2024-02-05 At Loss
2024-04-12 At Loss 2024-02-02 At Loss
2024-04-10 At Loss 2024-02-01 At Loss
2024-04-09 At Loss 2024-01-31 At Loss
2024-04-08 At Loss 2024-01-30 At Loss
2024-04-05 At Loss 2024-01-29 At Loss
2024-04-04 At Loss 2024-01-25 At Loss
2024-04-03 At Loss 2024-01-24 At Loss
2024-04-02 At Loss 2024-01-23 At Loss
2024-04-01 At Loss 2024-01-19 At Loss
2024-03-28 At Loss 2024-01-18 At Loss
2024-03-27 At Loss 2024-01-17 At Loss

Mangalam Drugs & Organics Ltd (BOM:532637) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. It is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise of sales in the Indian and overseas markets.